TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC
Status:
Completed
Trial end date:
2015-06-18
Target enrollment:
Participant gender:
Summary
Primary Objective:
To determine disease control rate (DCR) of TS-1® in patients with heavily pre-treated
metastatic colorectal cancer
Secondary Objectives:
- To determine objective response rate (ORR)
- To determine time to progression (TTP)
- To determine overall survival (OS)
- To assess incidence of adverse events (AEs), serious adverse events (SAEs) [Safety and
Tolerability]